Categories: News

LPW Training Services Named 2024 Best Company for Women to Work

Women’s Choice Award® Names LPW Training Services a 2024 Best Companies to Work for Women

SOMERVILLE, NJ / ACCESSWIRE / August 7, 2024 / LPW Training Services was recognized with three awards as a 2024 Best Companies to Work for Women, Inclusion, and Millennials. The Women’s Choice Award is the only distinction that identifies the nation’s best companies to work for based on robust criteria.

“As a minority and women-owned company, LPW values inclusiveness, which creates a culture of respect that allows people to embrace diversity of backgrounds, learning, experience, and thought. We promote excellence by attracting, engaging, and retaining diverse employees, including women, minorities, and millennials,” said LPW’s CEO and Founder, Liza Pizarro-White. “The Women’s Choice Award recognition reinforces that we are succeeding in our mission.”

The objective of the Women’s Choice Award Best Companies to Work for Women, Inclusion & Millennials is to identify companies that best 1) meet the general needs of all working women, such as offering work-life balance and well-being, 2) help women of multicultural backgrounds to navigate the workplace by dismantling systematic barriers and closing race-based gaps, and 3) help millennial women grow professionally and advance their careers. Each award category is given a composite score based on data compiled for the benefit provided and weighted according to a proprietary process. Companies surpassing the “highest standards” earn the Best Companies to Work Award. Companies that surpass a “highest standards” level earn the Best Companies to Work Award.

Criteria to earn a place on the Women’s Choice Award ‘Best Companies to Work’ list include:

“We take great pride in offering an objective and uniform reporting process so women can choose where to work with greater confidence. Companies that carry the Women’s Choice Award are celebrating their commitment to women and in this highly competitive marketplace, that’s smart business,” said Delia Passi, CEO and Founder of the Women’s Choice Award. “It’s an honor to recognize LPW Training as a Best Company to Work for their investment in women and their commitment to hire and retain top talent and, thereby, boosting their competitiveness.”

For more information, visit https://womenschoiceaward.com/best-companies

ABOUT LPW TRAINING SERVICES

LPW Training Services is an award-winning, minority and woman-owned, full-service learning and development company. With over 19 years of experience, we create innovative, meaningful, and impactful learning programs that increase adoption and proficiency and achieve the mission, goals, and objectives of the unique customers we proudly serve.

For more information, visit: https://lpwtraining.com

Contact Information

Christine Monclova
Marketing Coordinator
cmonclova@lpwtraining.com
(800) 620-0429

SOURCE: LPW Training Services

View the original press release on newswire.com.

Staff

Recent Posts

BioHarvest Sciences Reports Director’s Ongoing Key Role Following Resignation from Board

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 20, 2024) - BioHarvest Sciences Inc. (CSE:…

3 hours ago

NervGen Pharma to Present at the Unite 2 Fight Paralysis 19th Annual Science & Advocacy Symposium Focused on Spinal Cord Injury

Vancouver, British Columbia--(Newsfile Corp. - September 20, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB:…

3 hours ago

Water Tower Research Highlights Ainos VELDONA Clinical Trial for HIV+ Patients with Oral Warts

SAN DIEGO, CA / ACCESSWIRE / September 20, 2024 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or…

3 hours ago

Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead Product – Aversa(TM) Fentanyl Transdermal Patch

Nutriband signs trademark licensing agreement for Bitrex® brand denatonium benzoate, the most bitter substance in…

3 hours ago

Ipsen’s Iqirvo® (elafibranor) approved in the European Union as first new treatment for primary biliary cholangitis in nearly a decade

European Commission grants conditional marketing authorization for Iqirvo® (elafibranor), first-in-class new treatment for primary biliary…

3 hours ago

Novo Nordisk A/S: Monlunabant phase 2a trial in obesity successfully completed

Bagsværd, Denmark, 20 September 2024 – Novo Nordisk today announced headline results from a phase…

3 hours ago